Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

被引:0
作者
John P Zajicek
Wendy M Ingram
Jane Vickery
Siobhan Creanor
Dave E Wright
Jeremy C Hobart
机构
[1] University of Plymouth,Clinical Neurology Research Group, Peninsula College of Medicine and Dentistry
[2] University of Plymouth,Department of Medical Statistics
来源
BMC Neurology | / 10卷
关键词
Multiple Sclerosis; Multiple Sclerosis Patient; Expand Disability Status Scale; Glatiramer Acetate; Clinically Isolate Syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 128 条
[1]  
Giovannoni G(2001)Fatigue is not associated with raised inflammatory markers in multiple sclerosis Neurology 57 676-681
[2]  
Thompson AJ(1988)Multiple sclerosis: a serial study using MRI in relapsing patients Neurology 38 1511-1515
[3]  
Miller DH(1989)Pathogenesis of progressive multiple sclerosis Lancet 1 1322-1323
[4]  
Thompson EJ(1983)Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444-1452
[5]  
Isaac C(2007)Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial Ann Neurol 61 14-24
[6]  
Li DK(1999)The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force Mult Scler 5 244-250
[7]  
Genton M(2009)Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study Clin J Pain 25 211-217
[8]  
Jardine C(2008)Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey Health Qual Life Outcomes 6 100-1485
[9]  
Grochowski E(2004)Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population Mov Disord 19 1482-1037
[10]  
Palmer M(2007)Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study Mult Scler 13 1033-911